Document Detail


Development of an ultra-rapid diagnostic method based on heart-type fatty acid binding protein levels in the CSF of CJD patients.
MedLine Citation:
PMID:  20499272     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Creutzfeldt-Jakob disease (CJD) is a transmissible, fatal, neurodegenerative disease in humans. Recently, various drugs have been reported to be useful in the treatment of CJD; however, for such treatments to be useful it is essential to rapidly and accurately diagnose CJD. 124 CJD patients and 87 with other diseases causing rapid progressive dementia were examined. Cerebral spinal fluid (CSF) from CJD patients was analyzed by 2D-PAGE and the protein expression pattern was compared with that from healthy subjects. One of three CJD-specific spots was found to be fatty acid binding protein (FABP), and heart-type FABP (H-FABP) was analyzed as a new biochemical marker for CJD. H-FABP ELISA results were compared between CJD patients and patients with other diseases (n = 211). Visual readout accuracy of the Rapicheck(®) H-FABP test panel for CSF was analyzed using an independent measure of CSF H-FABP concentration. The distribution of H-FABP in the brains of CJD patients was examined by immunohistochemistry. ELISA sensitivity and specificity were 90.3% and 92.9%, respectively, and Rapicheck(®) H-FABP sensitivity and specificity were 87.9% and 96.0%, respectively. ELISA and Rapicheck(®) H-FABP assays provided comparable results for 14-3-3 protein and total tau protein. Elevated H-FABP levels were associated with an accumulation of abnormal prion protein, astrocytic gliosis, and neuronal loss in the cerebral cortices of CJD patients. In conclusion, Rapicheck(®) H-FABP of CSF specimens enabled quick and frequent diagnosis of CJD. H-FABP represents a new biomarker for CJD distinct from 14-3-3 protein and total tau protein.
Authors:
Yuki Matsui; Katsuya Satoh; Kazuo Mutsukura; Takuya Watanabe; Noriyuki Nishida; Hideo Matsuda; Masaichi Sugino; Susumu Shirabe; Katsumi Eguchi; Yasufumi Kataoka
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-25
Journal Detail:
Title:  Cellular and molecular neurobiology     Volume:  30     ISSN:  1573-6830     ISO Abbreviation:  Cell. Mol. Neurobiol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-04     Completed Date:  2011-01-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200709     Medline TA:  Cell Mol Neurobiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  991-9     Citation Subset:  IM    
Affiliation:
Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Care and Health Sciences, Fukuoka University, Jonan-ku, Fukuoka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
14-3-3 Proteins / cerebrospinal fluid
Aged
Aged, 80 and over
Animals
Biological Assay* / methods,  standards
Biological Markers / cerebrospinal fluid*
Creutzfeldt-Jakob Syndrome* / cerebrospinal fluid,  diagnosis
Electrophoresis, Gel, Two-Dimensional
Enzyme-Linked Immunosorbent Assay / standards
Fatty Acid-Binding Proteins / cerebrospinal fluid*
Female
Humans
Male
Middle Aged
Myocardium / chemistry*
Sensitivity and Specificity
tau Proteins / cerebrospinal fluid
Chemical
Reg. No./Substance:
0/14-3-3 Proteins; 0/Biological Markers; 0/Fatty Acid-Binding Proteins; 0/tau Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  No mitochondrial DNA deletions but more D-loop point mutations in repeated pregnancy loss.
Next Document:  Effect of temperature on excess post-exercise oxygen consumption in juvenile southern catfish (Silur...